Medical Supplies

Biblioteksgatan 25, P.O. Box 50 70
102 42 Stockholm
Sweden

Phone: (+46-8)44058-80
Fax: (+46-8)44058-90
http://www.bactiguard.com

Company Profile

About Bactiguard

The clinically proven solution for preventing hospital acquired infections
The company Bactiguard has the vision of becoming the world leader in reducing all device related hospital and care acquired infections. Through innovative technology and techniques, we are providing a clinically proven, practical and cost effective solution. The proof of Bactiguard® – over 80.000 patients in clinical studies, 60 million end users.

The product Bactiguard® consists of an extremely thin noble metal alloy, with antimicrobial and biocompatible properties. The unique physical and chemical properties of the Bactiguard® coating makes it applicable on any medical device.

Product Information
Catheters
In Vitro/In Vivo Efficacy

The anti-microbial properties of the Bactiguard® coating, has been proven for clinically relevant strains of both Gram-positive and Gram-negative bacteria as well as for fungi.
Toxicological testing shows that the antimicrobial property of the Bactiguard® coating is not achieved at the expense of its biocompatibility1.

Mouse fibroblasts; extracts from the Bactiguard® coated catheter did not show cytotoxic reactions.
Short and long term implantation studies; no differences in biological reactions compared to control.
Hemocompatibility; no tendency of increased platelet adhesion due to the Bactiguard® coating.

Urethral Applications

The noble metal alloy Bactiguard® coated latex urinary catheter has been proven to prevent urinary infections in many clinical investigations over the years. The bulk of the published clinical trial data includes close to 30 000 patients plus well over 50.000 patients in cohort studies. The average reduction of catheter associated urinary tract infection of about 30-40% can be directly related to the unique properties of the Bactiguard® coating of urinary catheters.
80.000 patients in clinical – average reduction of infection 30-40%
Blood Applications
A clinical study of Bactiguard® coated central venous catheters has also been carried out. It was concluded that the coating significantly reduced the incidence of infections by approximately 50% after thirteen days.